Cite
HARVARD Citation
Sakata, Y. et al. (2020). The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events. Asia-Pacific journal of clinical oncology. 16 (2), pp. e113-e117. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sakata, Y. et al. (2020). The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events. Asia-Pacific journal of clinical oncology. 16 (2), pp. e113-e117. [Online].